Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Marelli

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Bioconjugate Chemistry|March 27, 2019
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life ExtensionQing Li, Allison Barrett, Balakumar Vijayakrishnan, et al.
Protein Engineering, Design & Selection : PEDS|August 15, 2015
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation modelKarin Stenderup, Cecilia Rosada, Kurt Shanebeck, et al.
Nature Communications|October 10, 2018
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerFeng Chen, Kai Ma, Brian Madajewski, et al.
Bioconjugate Chemistry|August 6, 2019
A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with MaleimideAndre H St Amant, Fengying Huang, Jia Lin, et al.
Advanced Therapeutics|April 3, 2023
Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric CancerLi Zhang, Virginia Aragon-Sanabria, Anusha Aditya, et al.
Bioconjugate Chemistry|September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition ChemistryMichael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
Science Advances|March 6, 2021
PD-L1<sup>+</sup> neutrophils contribute to injury-induced infection susceptibilityAjitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Bioconjugate Chemistry|March 27, 2019
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life ExtensionQing Li, Allison Barrett, Balakumar Vijayakrishnan, et al.
Protein Engineering, Design & Selection : PEDS|August 15, 2015
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation modelKarin Stenderup, Cecilia Rosada, Kurt Shanebeck, et al.
Nature Communications|October 10, 2018
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerFeng Chen, Kai Ma, Brian Madajewski, et al.
Bioconjugate Chemistry|August 6, 2019
A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with MaleimideAndre H St Amant, Fengying Huang, Jia Lin, et al.
Advanced Therapeutics|April 3, 2023
Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric CancerLi Zhang, Virginia Aragon-Sanabria, Anusha Aditya, et al.
Bioconjugate Chemistry|September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition ChemistryMichael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
Science Advances|March 6, 2021
PD-L1<sup>+</sup> neutrophils contribute to injury-induced infection susceptibilityAjitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse, et al.
Pageof 7